The Story behind the Science: ATCC at 100 years
mBio · 05.11.2026
DOI: 10.1128/mbio.00893-26 ↗Kurz gefasst
Fachartikel in der Zeitschrift mBio, online erschienen am 05.11.2026. Verfasst von Raymond H Cypess und 1 weiteren Autor:innen. Beteiligte Einrichtung: American Type Culture Collection, Manassas, Virginia, USA. Die Arbeit nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
In 2025, ATCC celebrated its 100th anniversary, a longevity achieved by only a few organizations, and not too many individuals. During that century, ATCC grew from a small, donor-dependent collection of fewer than 200 microorganisms into the independent global biological resource center it is today. ATCC would not have been created and likely not have survived its early years without the involvement of ASM, the parent organization of ATCC. The scientists who founded ATCC, and those who followed, recognized the value of ATCC through its provision of reference standards as the essential tools and reagents required for the replication of experimental results. In this publication, we recognize ASM’s key role in the formal establishment of ATCC in 1925 and its sustained support of ATCC’s continuity. We begin with ATCC’s founding and early development, followed by the struggle to establish and maintain ATCC’s physical independence, and conclude with key aspects of ATCC’s global activities.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- American Type Culture Collection, Manassas, Virginia, USA.
ORCID-Profile: Frank P Simione
Zitieren
APA
Cypess, R. H., & Simione, F. P. (2026). The Story behind the Science: ATCC at 100 years. mBio. https://doi.org/10.1128/mbio.00893-26
Vancouver
Cypess RH, Simione FP. The Story behind the Science: ATCC at 100 years. mBio. 2026. doi:10.1128/mbio.00893-26
BibTeX
@article{Cypess2026,
author = {Cypess, Raymond H and Simione, Frank P},
title = {The Story behind the Science: ATCC at 100 years},
journal = {mBio},
year = {2026},
doi = {10.1128/mbio.00893-26}
}
EUVIMED